Erik Esveld
Directeur/Membre du Conseil chez BIOINVENT INTERNATIONAL AB
Profil
Erik Esveld is currently an Independent Director at BioInvent International AB.
He is also the Finance Director at Van Herk Groep BV.
In addition, he holds the position of Chief Financial Officer at Van Herk Investments BV since 2012.
Mr. Esveld is a Member-Supervisory Board at Agendia NV, Agendia, Inc., and SkylineDx BV.
Previously, Mr. Esveld served as a Director at Mendus AB, AEC Skyline Holding BV, Stichting Op Klompen Begonnen, Stichting Start2Cure, de Hoben GmbH, Campus Fraxinus Excelsior BV, and Ht Projecktentwicklung GmbH.
Mr. Esveld completed his graduate degree at Nyenrode Business Universiteit in 2020 and his undergraduate degree at Erasmus University Rotterdam in 1994.
Postes actifs de Erik Esveld
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Directeur/Membre du Conseil | 29/04/2021 |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Directeur Financier/CFO | 20/12/2005 |
Van Herk Groep BV
 Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | Directeur Financier/CFO | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Directeur/Membre du Conseil | 01/02/2016 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | - |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Directeur/Membre du Conseil | - |
Anciens postes connus de Erik Esveld
| Sociétés | Poste | Fin |
|---|---|---|
de Hoben GmbH
 de Hoben GmbH Real Estate DevelopmentFinance de Hoben GmbH is a private company that was founded in 2017 and engages in the buying and selling of land, buildings, and apartments. The company is based in Dusseldorf, Germany. | Directeur/Membre du Conseil | - |
| Ht Projecktentwicklung GmbH | Directeur/Membre du Conseil | - |
| Campus Fraxinus Excelsior BV | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Erik Esveld
| Nyenrode Business Universiteit | Graduate Degree |
| Erasmus University Rotterdam | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| MENDUS AB | Health Technology |
| Entreprise privées | 11 |
|---|---|
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Finance |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Van Herk Groep BV
Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | Finance |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Health Services |
| AEC Skyline Holding BV | |
| Stichting Op Klompen Begonnen | Miscellaneous |
| Stichting Start2Cure | Miscellaneous |
de Hoben GmbH
de Hoben GmbH Real Estate DevelopmentFinance de Hoben GmbH is a private company that was founded in 2017 and engages in the buying and selling of land, buildings, and apartments. The company is based in Dusseldorf, Germany. | Finance |
| Campus Fraxinus Excelsior BV | |
| Ht Projecktentwicklung GmbH |
